Healthcare and Life Sciences

Format: 2017-02-19
Format: 2017-02-19
January 27, 2017 | 94 Pages | SKU: IRTNTR11741

Overview of the ophthalmic femtosecond lasers market

Technavio’s market research analyst predicts the global ophthalmic femtosecond lasers market to grow steadily at a CAGR of above 6% by 2021. One of the primary growth drivers for this market is the rise in the incidences of cataract and rising older population. There has been a rise in the incidence of ophthalmic disorders among the population worldwide. Among all the ophthalmic disorders, cataract surgery is the most frequently performed operative procedure in the world. As per the National Eye Institute, between 2000 and 2010, several major changes were observed in the cataract surgery procedure and the cataract surgery devices used for the surgery. According to the experts, the number of the case for cataract surgeries will rise exponentially in the coming years. Also, the rise in the older population, both in developed and developing countries will positively influence the growth of the cataract device market, which, in turn, will induce growth in the ophthalmic femtosecond lasers market in the coming years.

In terms of geography, the Americas accounted for the maximum market share during 2016 and will continue to dominate the market for the next few years. The rising older population, leading to increasing incidences of cataract is the primary driver contributing to the growth of the ophthalmic femtosecond lasers market in the region. To treat the rising population of older adults, vendors are developing technologically advanced innovative products such as femtosecond laser systems. Moreover, improved healthcare support by governments and advances in technology will fuel the demand for


January 27, 2017 | 93 Pages | SKU: IRTNTR11727

Overview of the global short peripheral intravenous catheter (PIVC) market

Technavio’s market research analyst predicts the global short peripheral intravenous catheter (PIVC) market to grow steadily at a CAGR of above 6% by 2021. One of the major factors responsible for the growth of this market is the development of effective short PIVCs, whose demand is fuelled by the rapid advances in the medical technology. The growing advances in technologies have led to the development of catheters that significantly reduce hematoma-related complications and bloodstream infections. Also, vendors in the market are currently developing products that are efficient and provide greater patient comfort. For instance, in August 2015, AngioDynamics, a provider of innovative, minimally invasive medical devices for surgery, vascular access, and peripheral vascular disease and oncology, launched the BioFlo Midline catheter for short-term intravenous therapies. Moreover, other benefits like higher clinical efficiency and increased patient compliance will augment the growth of the short PIVC market during the forecast period.

In terms of geography, the Americas accounted for the maximum market share during 2016 and will continue to dominate the market for the next few years. Increasing hospitalization rates coupled with chronic disorders is the key factor propelling the growth of the PIVC market in the region. The US was the largest revenue contributor in the Americas primarily because of its increasing aging population. Further, the growing demand for injectable drugs in comparison to oral medications and the increasing healthcare expenditure will augment the


January 25, 2017 | 70 Pages | SKU: IRTNTR11121

Overview of the global stem cell therapy market

Technavio’s market research analyst predicts the global stem cell therapy market to grow steadily at a CAGR of around 36% by 2021. One of the primary factors driving this market’s growth is the limitations in traditional organ transplantations. The growing concerns with organ transplantations have driven the demand for stem cell therapy products. Conventional organ donation is associated with infection risk, immunosuppression risk, and rejection. Also, the demand for organs is increasing, and the physicians highly dependent on organ donors. To overcome these issues researchers are now exploring ways to identify the application of stem cell therapies in various transplants. For instance, pluripotent stem cells offer a potentially unlimited source of human cells, which can derive most of the cells in the body. Moreover, the graft rejection can be reduced with the stem cells, as these are grown using the same individual cells. These advantages in the transplantations of organs will result in the growth of the global stem cell therapy market.

In terms of geography, the Americas accounted for the maximum market share during 2016 and will continue to dominate the market for the next few years. The primary contributor to the dominance of this market is the increasing government funding for stem cell research in the region. This funding is largely focused on running clinical trials and developing new medicines for various diseases. The increasing demand for stem cell therapy products coupled with increasing investments in R&D activities in the US and Canada will augment the growth of the stem cell therapy market in the coming years.

Competitive


January 25, 2017 | 65 Pages | SKU: IRTNTR11705

Overview of the global MRSA testing market

The global MRSA testing market is anticipated to grow rapidly and will post a CAGR of more than 11% during the forecast period. The increasing demand for automation and system integration will drive the growth prospects for the global MRSA testing market for the next four years. Since fully automated and semi-automated systems in laboratories enable the doctors to carry out large volumes of tests, the productivity of the health care units improve. Since these systems allow end-users to efficiently handle large test volumes, the results obtained are more accurate and the overall workflow becomes more efficient. For instance, these system's software and graphical user interface (GUI) allow streamlined information management and offer solutions ranging from remote test ordering to sophisticated result analysis.

In terms of geography, the Americas accounted for the maximum market share during 2016 and will continue to dominate the market until the end of 2021. One of the major factors responsible for the market’s growth in the region is the presence of several vendors headquartered in the Americas that provide advanced treatment options. Also, the region is witnessing a high adoption rate of MRSA testing procedure for the diagnosis of various types of infections. Moreover, the market is witnessing an increasing support from the government and private organizations to carry out advanced research activities that involve assays and instruments, which, in turn,  will accelerate the market’s growth in the future.


January 24, 2017 | 68 Pages | SKU: IRTNTR11179

Overview of the global atopic dermatitis drugs market

The global atopic dermatitis drugs market is anticipated to grow at a steady rate and will post a CAGR of more than 4% during the forecast period. The growing prevalence of food allergies exacerbating atopic dermatitis will drive the growth prospects for the global atopic dermatitis drugs market in the forthcoming years. According to the industry research report, almost one-third of the children with atopic dermatitis are diagnosed with food allergy. For instance, according to research studies, 5%-10% of all children have atopic dermatitis, and one-third of them have a food allergy. One of the major factors responsible for the growing risk of severe atopic dermatitis in infancy is related to food sensitization, which is commonly associated with food allergy. It has been observed that these allergies mainly result from the cow’s milk, chicken eggs, peanuts, wheat, soy, nuts, and fish.

The launch of the first biologic for atopic dermatitis will drive the market prospects for the global atopic dermatitis drugs market for the next four years. Biologic agents must have the ability to provide control over the disease when a patient is suffering from moderate to severe atopic dermatitis. It has also been observed that at present, the market players have not been able to provide effective therapeutics to meet the increasing number of unmet needs. However, according to the market research and analysis, patients with atopic dermatitis do not respond to other treatments as they do with biologics, which targets adaptive immune responses


January 23, 2017 | 158 Pages | SKU: IRTNTR11669

Overview of the medical imaging market

Extensive research carried out by the analysts at Technavio has shown that the global medical imaging market will witness steady growth at a moderate CAGR of close to 5% during the forecast period. The growing demand for portable imaging equipment is one of the primary factors driving this market’s growth. Portable imaging equipment offers ease of use and point-of-care applications, which is leading to their increased adoption not only in hospitals but also as a part of homecare. Moreover, there is also an augmented demand for portable devices in the emergency care units for easier and quick usage, faster interventions for acute events, and better monitoring. Owing to the recent advances in technology, vendors are increasingly focussing on incorporating these portable imaging devices with hi-tech features that are at par with the stationary medical imaging equipment. For instance, portable ultrasound devices are equipped the wireless features like Bluetooth, and near-field communication to deliver highly sophisticated home-based healthcare service for individuals. Similarly, portable X-ray systems are lightweight and convenient to use as the X-ray images can be sent from anywhere in the hospital, saving a lot of time.

In terms of geography, the Americas dominated the global medical imaging market during 2016 and will continue to lead the market over the next four years. The medical imaging market in the Americas is largely dominated by the US owing to the better infrastructure and awareness about


Pages